| Comparison of ischemic side effects of levosimendan and dobutamine with integrated backscatter analysis. | |
| | |
MedLine Citation:
|
PMID: 19353707 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Levosimendan improves cardiac contractility without increasing oxygen consumption. However, its effects on ischemia were not supported with the utilization of a noninvasive parameter of myocardial characterization. HYPOTHESIS: The changes observed in integrated backscatter (IBS) may be reflective of change in myocardial ischemia. In this study, the effect of levosimendan on ischemia detected by IBS was evaluated in patients with ischemic heart failure (HF). METHODS: Patients who had LVEF < 40% and NYHA III-IV symptoms of HF were included in this study. Patients were randomized to levosimendan (n = 21), or to dobutamine (n = 25) groups. The cyclic variation of integrated backscatter (CVIBS) was determined as the difference between the maximal and minimal values in a cardiac cycle, average of three consecutive beats. CVIBS was taken from the mid-anteroseptal, mid-inferior, and mid-posterolateral areas of the parasternal short axis images before the drug administration and at the end of the 24-hour infusion period. RESULTS: Baseline characteristics and concomitant medications were similar in both groups. A significant reduction in CVIBS was detected in anteroseptal (7.6 +/- 1.4 dB versus 5.9 +/- 0.8 dB, p = 0.01), inferior wall (7.4 +/- 0.8 dB versus 6.7 +/- 1.5 dB, p = 0.03), and posterolateral wall (9.0 +/- 1.2 dB versus 8.2 +/- 0.6 dB, p = 0.04) after dobutamine administration, while no significant changes were observed in the levosimendan group in all walls. CONCLUSIONS: Unlike dobutamine, levosimendan may not induce myocardial ischemia as shown by CVIBS at commonly used dosages in the setting of decompensated HF without active ischemia. |
| | |
Authors:
|
Hamza Duygu; Sanem Nalbantgil; Mehdi Zoghi; Filiz Ozerkan; Ahmet Yildiz; Azem Akilli; Mustafa Akin |
Related Documents
:
|
12931107 - Relationship between dobutamine response of dyssynergic myocardium and angiographically... 15113007 - Improved interpretation of dobutamine stress echocardiography following 4 months of sys... 2187517 - Preoperative evaluation of cardiac risk using dobutamine-thallium imaging in vascular s... 10979027 - The role of stress echocardiography in children. 22160667 - Characterization of the failing murine heart in a desmin knock-out model using a clinic... 12834567 - Cardiac resynchronization therapy for advanced heart failure. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Clinical cardiology Volume: 32 ISSN: 0160-9289 ISO Abbreviation: Clin Cardiol Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-13 Completed Date: 2009-06-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7903272 Medline TA: Clin Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 187-92 Citation Subset: IM |
Affiliation:
|
Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey. hamzakard@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiotonic Agents
/
administration & dosage,
adverse effects,
diagnostic use* Dobutamine / administration & dosage, adverse effects, diagnostic use* Electrocardiography / methods Female Humans Hydrazones / administration & dosage, adverse effects, diagnostic use* Image Interpretation, Computer-Assisted Injections, Intravenous Male Middle Aged Myocardial Ischemia / diagnosis*, radiography Predictive Value of Tests Pyridazines / administration & dosage, adverse effects, diagnostic use* Stroke Volume Treatment Outcome Ventricular Function, Left / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 0/Hydrazones; 0/Pyridazines; 131741-08-7/simendan; 34368-04-2/Dobutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stem cells improve left ventricular function in acute myocardial infarction.
Next Document: Effects of statins on endothelial function in patients with coronary artery disease.